Cookies disclaimer

Estoy de acuerdo utilizamos cookies para mejorar la experiencia de navegación del usuario y para estudiar cómo se utiliza nuestro sitio web. si navega por nuestro sitio web, estará aceptando el uso de las cookies en las condiciones establecidas en la presente política de cookies. esta política puede ser actualizada, por lo que le invitamos a revisarla de forma regular

54965-24-1 - Tamoxifen citrate - cis-1-(4-Dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene citrate - J60955 - Alfa Aesar

J60955 Tamoxifen citrate

Número CAS
54965-24-1
Nombre Alternativo
cis-1-(4-Dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene citrate

Tamaño Precio ($) Cantidad Disponibilidad
1g 192,61
5g 468,00
Añadir al carrito Añadir al presupuesto al por mayor Ver artículo

Tamoxifen citrate

MDL
MFCD00058321
EINECS
259-415-2

Propiedades químicas

Fórmula
C26H29NO.C6H8O7
Peso molecular
563.65
Formulario
White to off-white powder
Sensibilidad
Light Sensitive & Hygroscopic
Solubilidad
Soluble in methanol (50 mg/ml with heat) or ethanol (10 mg/ml with sonication); very slightly soluble in water (0.3 mg/L @ 20°C; the pH is approximately 3.0-3.5), 0.02 N HCl (0.2 mg/ml @ 37°C)4, acetone ,chloroform,and DMSO(100mM)

Aplicaciones

Tamoxifen citrate is used as an antiestrogen with potent anti-cancer and PKC inhibitory activities. Tamoxifen Citrate functions as an estrogen receptor antagonist in breast tissue. Tamoxifen Citrate is an agonist towards this receptor in tissues of the endometrium. Tamoxifen Citrate inhibits DNA synthesis and transcription by recruiting co-repressors, which stop estrogen from interacting with genes. When combined with PAX2, Tamoxifen Citrate can inhibit the proliferation of ERBB2. It is also a high affinity activator of the GPR30 receptor. Tamoxifen Citrate is an activator of Estrogen Receptor.

Notas

Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Recommended storage temperature: 2 - 8°C. Keep away from strong oxidizing agents.

Referencias documentales

Wakeling et al. Non-steroidal anti-estrogens - receptor binding and biological response in rat uterus, rat mammary carcinoma and human breast cancer cells. J.Steroid.Biochem. 1984, 20,(1), 111-20.

Paul et al. Both the immunosuppressant SR31747 and the antioestrogen tamoxifen bind to an emopamil-insensitive site of mammalian Δ8-Δ7 sterol isomerase. J.Pharmacol.Exp.Ther. 1998, 285,(3), 1296-302.

Indicaciones de peligro y de precaución del GHS

Indicaciones de peligro (UE): H350-H360-H362-H302

May cause cancer. May damage fertility or the unborn child. May cause harm to breast-fed children. Harmful if swallowed.

Indicaciones de precaución: P263-P260-P201-P281-P264-P270-P301+P312-P308+P313-P405-P501a

Avoid contact during pregnancy/while nursing. Do not breathe dust/fume/gas/mist/vapours/spray. Obtain special instructions before use. Use personal protective equipment as required. Wash thoroughly after handling. Do not eat, drink or smoke when using this product. IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell. IF exposed or concerned: Get medical advice/attention. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.

Otras referencias

Merck
14,9048
Código de tarifa arancelaria unificado
2922.29
TSCA
No
RTECS
KH2387000

Recomendado

Visto recientemente

Productos químicos

Ciencias de la vida

Metales & materiales

Catalizadores

Análisis y material de laboratorio